StockData
CervoMed Inc. logo

CervoMed Inc. (CRVO) stock

CRVONasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 5/30
$1.50−0.17 (-10.18%)

Close on Nov 17, 2026Market cap $22.68MP/E –Yield –

CervoMed total assets

Total assets on the balance sheet at the end of each period.

CervoMed's total assets was $25.99M at Jun 30, 2026. For fiscal 2025 it was $22.88M, down 46.9% from the year before. Over ten years it grew 26.0% a year on average. The highest annual figure on record is $43.08M in fiscal 2024.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$22.88M-46.9%
FY2024Dec 31, 2024$43.08M+332.0%
FY2023Dec 31, 2023$9.97M+139.9%
FY2022Dec 31, 2022$4.16M-89.0%
FY2021Dec 31, 2021$37.84M+36.5%
FY2020Dec 31, 2020$27.73M+15.0%
FY2019Dec 31, 2019$24.11M+32.5%
FY2018Dec 31, 2018$18.20M-30.4%
FY2017Dec 31, 2017$26.15M+49.5%
FY2016Dec 31, 2016$17.48M+668.0%
FY2015Dec 31, 2015$2.28M-94.7%
FY2014Dec 31, 2014$42.78M+133.2%
FY2013Dec 31, 2013$18.34M+649.9%
FY2012Dec 31, 2012$2.45M-33.4%
FY2011Dec 31, 2011$3.67M-34.1%
FY2010Dec 31, 2010$5.58M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$25.99M-31.7%
Q1 FY2026Mar 31, 2026$15.11M-60.8%
Q4 FY2025Dec 31, 2025$22.88M-46.9%
Q3 FY2025Sep 30, 2025$30.61M-37.4%
Q2 FY2025Jun 30, 2025$38.08M-28.4%
Q1 FY2025Mar 31, 2025$38.58M+382.4%
Q4 FY2024Dec 31, 2024$43.08M+332.0%
Q3 FY2024Sep 30, 2024$48.88M+306.1%
Q2 FY2024Jun 30, 2024$53.19M+1481.1%
Q1 FY2024Mar 31, 2024$8.00M+102.8%
Q4 FY2023Dec 31, 2023$9.97M+139.9%
Q3 FY2023Sep 30, 2023$12.04M-54.3%
Q2 FY2023Jun 30, 2023$3.36M-88.5%
Q1 FY2023Mar 31, 2023$3.94M-88.3%
Q4 FY2022Dec 31, 2022$4.16M-89.0%
Q3 FY2022Sep 30, 2022$26.32M-35.6%
Q2 FY2022Jun 30, 2022$29.18M-44.6%
Q1 FY2022Mar 31, 2022$33.57M-40.3%
Q4 FY2021Dec 31, 2021$37.84M+36.5%
Q3 FY2021Sep 30, 2021$40.88M+28.1%
Q2 FY2021Jun 30, 2021$52.71M+46.4%
Q1 FY2021Mar 31, 2021$56.21M+167.0%
Q4 FY2020Dec 31, 2020$27.73M+15.0%
Q3 FY2020Sep 30, 2020$31.92M+97.1%
Q2 FY2020Jun 30, 2020$35.99M+90.1%
Q1 FY2020Mar 31, 2020$21.06M+31.7%
Q4 FY2019Dec 31, 2019$24.11M+32.5%
Q3 FY2019Sep 30, 2019$16.20M-31.4%
Q2 FY2019Jun 30, 2019$18.93M-36.8%
Q1 FY2019Mar 31, 2019$15.99M-52.1%
Q4 FY2018Dec 31, 2018$18.20M-30.4%
Q3 FY2018Sep 30, 2018$23.59M-16.7%
Q2 FY2018Jun 30, 2018$29.94M-11.7%
Q1 FY2018Mar 31, 2018$33.37M-8.2%
Q4 FY2017Dec 31, 2017$26.15M+49.5%
Q3 FY2017Sep 30, 2017$28.33M+48.7%
Q2 FY2017Jun 30, 2017$33.91M–
Q1 FY2017Mar 31, 2017$36.34M–
Q4 FY2016Dec 31, 2016$17.48M–
Q3 FY2016Sep 30, 2016$19.05M–

More CervoMed figures

See a number that looks wrong?